The impact of immune checkpoint inhibitors on prognosis in unresectable hepatocellular carcinoma treated with TACE and lenvatinib: a meta-analysis

BackgroundCombination of multiple therapies is a common approach to treating patients with unresectable hepatocellular carcinoma (uHCC). The impact of immune checkpoint inhibitors (ICIs) on prognosis in uHCC patients treated with transarterial chemoembolization (TACE) and lenvatinib remains unclear....

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Wei Zhang, Zirong Liu, Hongjin Liu, Zhangkan Huang, Xiaozhun Huang, Lin Xu, Xu Che, Zhengyin Zhan
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2025-05-01
Schriftenreihe:	Frontiers in Immunology
Schlagworte:	hepatocellular carcinoma transarterial chemoembolization lenvatinib immune checkpoint inhibitor PD-1 inhibitor
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1573505/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!